One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-136000
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: Harvard University, Dana-Farber Cancer Institute, Institut Català d'Oncologia, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Centre Hospitalier Universitaire de Poitiers, Baptist Cancer Center, Rush University Medical Center, University of Florida, Oncopeptides (Sweden), Memorial Sloan Kettering Cancer Center, Baylor Medical Center at Garland, Oncology Institute of Hope and Innovation, Hospital Universitario Quirónsalud Madrid, University of Pittsburgh, French National Centre for Scientific Research, Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Inserm, Nantes Université, University of Angers, Clinica Universidad de Navarra, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Instituto de Investigación Biomédica de Salamanca, University of Bologna
HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)-Analysis of Adverse Events Related to Hospitalizations
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
